SALVIA, Roberto
 Distribuzione geografica
Continente #
EU - Europa 12.173
NA - Nord America 11.902
AS - Asia 6.157
SA - Sud America 133
AF - Africa 105
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 30.509
Nazione #
US - Stati Uniti d'America 11.812
GB - Regno Unito 4.196
CN - Cina 3.853
SG - Singapore 1.805
IT - Italia 1.519
SE - Svezia 1.195
RU - Federazione Russa 1.141
IE - Irlanda 1.078
FR - Francia 1.020
DE - Germania 830
FI - Finlandia 596
UA - Ucraina 206
JP - Giappone 107
BR - Brasile 92
BE - Belgio 84
NL - Olanda 78
TG - Togo 77
CA - Canada 69
KR - Corea 65
CZ - Repubblica Ceca 60
TR - Turchia 57
ID - Indonesia 46
HK - Hong Kong 38
VN - Vietnam 35
IN - India 32
AU - Australia 25
IR - Iran 23
AT - Austria 20
IL - Israele 16
LT - Lituania 14
ES - Italia 13
CL - Cile 12
LV - Lettonia 12
CH - Svizzera 10
MA - Marocco 10
MX - Messico 10
PT - Portogallo 10
KG - Kirghizistan 9
LU - Lussemburgo 9
PL - Polonia 9
AZ - Azerbaigian 8
EU - Europa 8
GR - Grecia 8
PK - Pakistan 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
BG - Bulgaria 7
DK - Danimarca 7
EG - Egitto 7
NO - Norvegia 7
AR - Argentina 6
IQ - Iraq 6
PA - Panama 6
PE - Perù 6
SK - Slovacchia (Repubblica Slovacca) 6
BO - Bolivia 5
TW - Taiwan 5
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
NZ - Nuova Zelanda 4
PH - Filippine 4
RS - Serbia 4
TH - Thailandia 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
BD - Bangladesh 3
CO - Colombia 3
EC - Ecuador 3
EE - Estonia 3
JO - Giordania 3
MY - Malesia 3
NG - Nigeria 3
SI - Slovenia 3
VE - Venezuela 3
AM - Armenia 2
CR - Costa Rica 2
GH - Ghana 2
HR - Croazia 2
IS - Islanda 2
JM - Giamaica 2
KZ - Kazakistan 2
MK - Macedonia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HN - Honduras 1
KH - Cambogia 1
ME - Montenegro 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
Totale 30.508
Città #
Southend 3.902
Chandler 2.453
Singapore 1.515
Jacksonville 1.367
Woodbridge 1.069
Dublin 1.048
Ashburn 708
Ann Arbor 646
Beijing 602
Houston 544
Verona 448
Lawrence 374
Princeton 374
Wilmington 351
Jinan 348
New York 305
Nanjing 291
Shenyang 255
Helsinki 226
Sindelfingen 185
Redmond 177
Hebei 170
Tianjin 130
Haikou 127
Hangzhou 116
Zhengzhou 111
Ningbo 107
Seattle 106
Taiyuan 94
Changsha 93
Milan 91
Tokyo 89
Nanchang 88
Taizhou 84
Brussels 81
Santa Clara 81
Lancaster 79
Guangzhou 78
Lomé 77
Boardman 75
Jiaxing 73
Fairfield 70
Seoul 63
Los Angeles 61
Washington 55
Bologna 52
Redwood City 52
Brno 51
Moscow 51
Dallas 48
Falls Church 45
Fuzhou 45
Jakarta 44
Norwalk 44
Kent 43
Lappeenranta 42
Rome 41
Lanzhou 39
San Francisco 39
Toronto 39
Munich 36
Düsseldorf 33
Hong Kong 33
Amsterdam 31
Falkenstein 30
Dong Ket 25
London 23
Auburn Hills 22
Dongguan 22
Chicago 21
Frankfurt am Main 20
Shanghai 17
Dearborn 15
Ottawa 15
Padova 15
Vienna 15
Romola 13
Cedar Knolls 12
Chions 12
Menlo Park 12
Sydney 12
Philadelphia 11
São Paulo 11
Wuhan 11
Cambridge 10
Clearwater 10
Genova 10
Nuremberg 10
Stockholm 10
Vicenza 10
Bishkek 9
Monza 9
San Diego 9
Malatya 8
Paris 8
Phoenix 8
Riga 8
Baku 7
Columbus 7
Edinburgh 7
Totale 20.669
Nome #
Resezione intermedia e pancreasectomia distale per neoplasie benigne del pancreas: confronto per complicanze postoperatorie e costi 224
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 157
Triple approach strategy for patients with locally advanced pancreatic carcinoma 146
Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up. 143
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 141
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 137
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 136
Pancreatic Hepatoid Carcinoma: A Review of the Literature 135
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 134
Genomic analyses identify molecular subtypes of pancreatic cancer 134
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 131
Incidence of cancer in the course of chronic pancreatitis 131
Role of unlabelled somatostatin analogues in the prevention of complications after elective pancreatic and peripancreatic surgery: a critical review 129
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 124
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 123
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 122
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 122
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma 121
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 120
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 119
Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. 118
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 117
Cistoadenomi e Cistoadenocarcinomi dela Pancreas: inquadramento generale e strategia chirurgica 116
Results of a surveillance protocol for pancreatic BD-IPMNs 116
Splice variants as novel targets in pancreatic ductal adenocarcinoma 116
Early detection of pancreatic cancer following the diagnosis of chronic pancreatitis. 115
Obstructive chronic pancreatitis and/or intraductal papillary mucinous neoplasms (IPMNs): a 21-year long case report. 114
Enucleation of pancreatic neoplasms. 113
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 113
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 113
Genomic characterization of hepatoid tumors: context matters 113
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma 112
Secretin-enhanced MRCP in the Evaluation of IPMTs of the Collateral Branches 110
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 109
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 109
Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results 108
Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study 106
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 106
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years. 106
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 106
Somatostatin analogues and pancreatic fistulas 105
Pancreatic fistola rate after pancreatic resection. The importance of definition. 105
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 105
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 105
Use of antibiotics in necrotizing pancreatitis 104
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 104
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Results of a prospective protocol on the management of 109 consecutive patients. 103
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 103
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions 103
Prevention of sepsis in acute pancreatitis 102
The spectrum of Intraductal tumours 102
Virtual analysis of pancreatic cystic lesion fluid content by ultrasound acoustic radiation force impulse quantification. 102
Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization 102
Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis 101
Cytoreductive surgery in advanced endocrine tumors of the pancreas 101
Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study. 101
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 101
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. 101
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 100
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 100
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 100
Prophylaxis for septic complications in acute necrotizing pancreatitis 99
(Intraductal papillary mucinous tumors) Clinical manifestations and therapeutic management. 99
A root-cause analysis of mortality following major pancreatectomy 99
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 99
Gα15 in early onset of pancreatic ductal adenocarcinoma 99
[Closed surgical treatment in acute severe pancreatitis] 98
The role of laparoscopy in advanced pancreatic cancer diagnosis. 97
Assessment and treatment of severe pancreatitis 97
Outcome of open necrosectomy in acute pancreatitis. 97
Trattamento palliativo del carcinoma duttale della testa del pancreas. Nostra esperienza sul ruolo della chirurgia derivativa 96
Value of regional lymphadenectomy in pancreatic cancer. 95
Anastomotic leakage in pancreatic surgery. 95
Anastomotic leakage in pancreatic surgery. 95
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 95
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 95
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 95
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 95
Beyond Pancreatic Cyst Epithelium: Evidence of Ovarian-Like Stroma in EUS-Guided Through-the-Needle Micro-Forceps Biopsy Specimens 95
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 95
Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for symtoms and see at imaging or vice versa? 94
Duct-to-mucosa versus end-to-side pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: Results of a prospective randomized trial 94
Variation of tumoral marker after radiofrequency ablation of pancreatic adenocarcinoma 94
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 93
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 93
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After 93
Delaying surgery for patients with a previous SARS-CoV-2 infection 93
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 93
To what extent is surgery superior to endoscopic therapy in the management of chronic pancreatitis? 92
Prospective study of the detection and treatment of small tumors of the head of the pancreas 92
Anastomotic leakeage in pancreatic surgery 92
Multicenter, Prospective Trial of Selective Drain Management for Pancreatoduodenectomy Using Risk Stratification 92
The determinant factors of recurrence following resection for ductal pancreatic cancer. 92
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 92
The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 15-3. 91
Pleomorphic liposarcoma of the axilla metastatic to the pancreas. 91
Anastomotic leakage in pancreatic surgery. 91
Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer 91
The role of surgery in the major early complications of severe acute pancreatitis 90
A single istitution experience with fistulojejunostomy for external pancreatic fistulas 90
Totale 10.793
Categoria #
all - tutte 130.116
article - articoli 125.476
book - libri 0
conference - conferenze 1.535
curatela - curatele 0
other - altro 93
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.012
Totale 260.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.427 0 0 0 0 0 0 315 167 121 217 223 384
2020/20213.575 431 542 179 658 362 381 125 137 184 89 315 172
2021/20222.926 271 700 58 193 114 105 73 198 146 76 258 734
2022/20237.190 459 779 594 1.193 590 1.700 148 559 815 73 169 111
2023/20244.246 155 362 390 510 456 648 267 278 64 168 703 245
2024/20254.338 583 569 408 1.724 614 353 87 0 0 0 0 0
Totale 31.147